8-101666577-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_024915.4(GRHL2):​c.1764-12C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000758 in 1,529,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000072 ( 0 hom. )

Consequence

GRHL2
NM_024915.4 intron

Scores

2
Splicing: ADA: 0.0001986
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -3.02

Publications

1 publications found
Variant links:
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 28
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: STRONG Submitted by: ClinGen
  • posterior polymorphous corneal dystrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
  • nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital fibrosis of extraocular muscles
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 8-101666577-C-G is Benign according to our data. Variant chr8-101666577-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 228732.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000719 (99/1377384) while in subpopulation MID AF = 0.00124 (7/5634). AF 95% confidence interval is 0.000582. There are 0 homozygotes in GnomAdExome4. There are 51 alleles in the male GnomAdExome4 subpopulation. Median coverage is 24. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL2NM_024915.4 linkc.1764-12C>G intron_variant Intron 15 of 15 ENST00000646743.1 NP_079191.2
GRHL2NM_001330593.2 linkc.1716-12C>G intron_variant Intron 15 of 15 NP_001317522.1
GRHL2NM_001440448.1 linkc.1716-12C>G intron_variant Intron 15 of 15 NP_001427377.1
GRHL2NM_001440447.1 linkc.1763+2059C>G intron_variant Intron 15 of 15 NP_001427376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL2ENST00000646743.1 linkc.1764-12C>G intron_variant Intron 15 of 15 NM_024915.4 ENSP00000495564.1
GRHL2ENST00000395927.1 linkc.1716-12C>G intron_variant Intron 15 of 15 2 ENSP00000379260.1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152128
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000104
AC:
26
AN:
251028
AF XY:
0.0000958
show subpopulations
Gnomad AFR exome
AF:
0.000370
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000719
AC:
99
AN:
1377384
Hom.:
0
Cov.:
24
AF XY:
0.0000739
AC XY:
51
AN XY:
690308
show subpopulations
African (AFR)
AF:
0.000347
AC:
11
AN:
31726
American (AMR)
AF:
0.000202
AC:
9
AN:
44608
Ashkenazi Jewish (ASJ)
AF:
0.000117
AC:
3
AN:
25622
East Asian (EAS)
AF:
0.000153
AC:
6
AN:
39268
South Asian (SAS)
AF:
0.000177
AC:
15
AN:
84578
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53396
Middle Eastern (MID)
AF:
0.00124
AC:
7
AN:
5634
European-Non Finnish (NFE)
AF:
0.0000348
AC:
36
AN:
1035014
Other (OTH)
AF:
0.000209
AC:
12
AN:
57538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152246
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41532
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000170

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 18, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1764-12C>G variant in GRHL2 has been reported by our laboratory in one ind ividual with hearing loss. This variant was identified in 5/16156 South Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs371424751); however, its frequency is not high enough to rule out a pathogenic role. This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing; however, this information is not pr edictive enough to rule out pathogenicity. In summary, the clinical significance of the c.1764-12C>G variant is uncertain. -

not provided Benign:1
Apr 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.012
DANN
Benign
0.33
PhyloP100
-3.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00020
dbscSNV1_RF
Benign
0.10
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371424751; hg19: chr8-102678805; API